Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-10 Sale | 2024-01-12 9:55 pm | Vera Therapeutics Inc. | VERA | COMMODORE CAPITAL LP 10% Owner | 1,050,000 | $18 | $18,900,000 | 4,400,000 (Indirect) | View |
| 2023-08-07 Purchase | 2023-08-09 4:10 pm | Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner | 775,756 | $23.15 | $17,961,079 | 1,575,000 (Indirect) | View |
| 2023-06-20 Purchase | 2023-06-22 4:10 pm | Vera Therapeutics Inc. | VERA | COMMODORE CAPITAL LP 10% Owner | 448,217 | $15.17 | $6,799,004 | 5,450,000 (Indirect) | View |
| 2023-02-23 Purchase | 2023-02-27 5:14 pm | Enliven Therapeutics Inc. | ELVN | COMMODORE CAPITAL LP 10% Owner | 622 | $22.07 | $13,723 | 2,178,531 (Indirect) | View |
| 2023-02-21 Purchase | 2023-02-23 4:05 pm | IMARA Inc. | IMRA | COMMODORE CAPITAL LP 10% Owner | 31,759 | $5.1481 | $163,498 | 2,872,513 (Indirect) | View |
| 2022-11-14 Sale | 2022-11-16 4:05 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 3,250,000 | $0.706 | $2,294,500 | 461,286 (Indirect) | View |
| 2021-11-24 Purchase | 2021-11-29 4:30 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 2,922 | $5.42 | $15,837 | 3,711,286 (Indirect) | View |
| 2021-11-19 Purchase | 2021-11-23 4:30 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 13,204 | $5.4778 | $72,329 | 3,708,364 (Indirect) | View |
| 2021-11-10 Purchase | 2021-11-12 4:31 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 17,563 | $5.9404 | $104,332 | 3,695,160 (Indirect) | View |
| 2021-11-08 Purchase | 2021-11-10 4:30 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 560 | $5.99 | $3,354 | 3,677,597 (Indirect) | View |
| 2021-11-04 Purchase | 2021-11-08 4:33 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 9,200 | $5.9393 | $54,642 | 3,677,037 (Indirect) | View |
| 2021-11-02 Purchase | 2021-11-04 4:31 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 8,880 | $5.64 | $50,083 | 3,667,837 (Indirect) | View |
| 2021-10-29 Purchase | 2021-11-02 4:30 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 44,651 | $5.71 | $254,957 | 3,658,957 (Indirect) | View |
| 2021-10-27 Purchase | 2021-10-29 4:30 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 54,663 | $5.4776 | $299,422 | 3,614,306 (Indirect) | View |
| 2021-10-21 Purchase | 2021-10-25 4:31 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 60,445 | $5.4503 | $329,442 | 3,559,643 (Indirect) | View |
| 2021-10-19 Purchase | 2021-10-21 4:30 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 128,243 | $5.1873 | $665,237 | 3,499,198 (Indirect) | View |
| 2021-10-15 Purchase | 2021-10-19 5:13 pm | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 162,194 | $4.8389 | $784,845 | 3,370,955 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-04 Option Award | 2023-10-06 4:05 pm | 2023-10-04 N/A | Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner | 5,872,944 | $0 | 5,872,944 (Indirect) | View |
Ownership | 2023-08-09 4:05 pm | N/A N/A | Vistagen Therapeutics Inc. | VTGN | COMMODORE CAPITAL LP 10% Owner | 0 | $0 | 799,244 (Indirect) | View |
Ownership | 2023-06-22 4:05 pm | N/A N/A | Vera Therapeutics Inc. | VERA | COMMODORE CAPITAL LP 10% Owner | 0 | $0 | 5,001,783 (Indirect) | View |
Ownership | 2023-03-03 4:05 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | COMMODORE CAPITAL LP 10% Owner | 0 | $0 | 35,700,000 (Indirect) | View |
| 2023-02-23 Other | 2023-02-27 5:14 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | COMMODORE CAPITAL LP 10% Owner | 729,891 | $0 | 2,178,531 (Indirect) | View |
Ownership | 2023-02-21 4:06 pm | N/A N/A | IMARA Inc. | IMRA | COMMODORE CAPITAL LP 10% Owner | 0 | $0 | 2,840,754 (Indirect) | View |
Ownership | 2021-10-19 5:09 pm | N/A N/A | Satsuma Pharmaceuticals Inc. | STSA | COMMODORE CAPITAL LP 10% Owner | 0 | $0 | 3,208,761 (Indirect) | View |